Safety and Immunogenicity of the Recombinant Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 18 Years and Older
Clinical trial NCT06904222 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06904222
- Sponsor
- Guangzhou Patronus Biotech Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-15
- Primary completion
- 2026-08-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.